This inventor holds 1 USPTO granted patent. Top assignee: Medical Biological Laboratories Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Kazue Watanabe: Innovator in T Cell Receptor Technology
Introduction
Kazue Watanabe is a prominent inventor based in Ina, Japan. She has made significant contributions to the field of immunology, particularly in the development of T cell receptor technologies. Her innovative work has the potential to advance cancer treatment and improve patient outcomes.
Latest Patents
Kazue Watanabe holds a patent for a method that efficiently proliferates and cultures cytotoxic T lymphocytes (CTLs) specific to WT1 peptides under limiting dilution conditions. This groundbreaking method allows for the successful generation of CTLs that can recognize both wildtype and mutant WT1 specific peptides presented by HLA-A*24:02. This advancement is crucial for developing targeted immunotherapies.
Career Highlights
Watanabe is associated with Medical & Biological Laboratories Co., Ltd., where she continues to push the boundaries of research in cellular therapies. Her work has garnered attention for its innovative approach to T cell activation and proliferation.
Collaborations
Kazue Watanabe collaborates with Shingo Toji, who is also involved in the research and development of T cell receptor technologies. Their partnership exemplifies the importance of teamwork in advancing scientific discoveries.
Conclusion
Kazue Watanabe's contributions to T cell receptor technology highlight her role as a leading inventor in the field of immunology. Her innovative methods have the potential to transform cancer treatment and improve therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile